Roche's Actemra has been in high demand since its ... 150 mg or 200 mg pre-filled syringes or auto-injectors – will be short until early 2022 based on current demand. Back in August, Roche's ...

Roche’s Actemra may help fight pandemic after all with phase 3 trial results showing it cut the chances of COVID-19 patients, mainly from higher risk minority ethnic backgrounds with pneumonia ...

In addition to bone disorders such as active rheumatoid arthritis and polyarticular juvenile idiopathic arthritis, tocilizumab was also cleared to treat COVID-19 during the pandemic. According to ...